Acquired angioedema can be the first symptom of underlying conditions such as lymphoma. In those cases, cancer treatment…
Alejandra Viviescas, PhD.
Alejandra has a PhD in Genetics from São Paulo State University (UNESP) and is currently working as a scientific writer, editor, and translator. As a writer for BioNews, she is fulfilling her passion for making scientific data easily available and understandable to the general public. Aside from her work with BioNews, she also works as a language editor for non-English speaking authors and is an author of science books for kids.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alejandra Viviescas, PhD.
Kalbitor (ecallantide) is a potential treatment for angioedema attacks that do not respond to medication, in adolescents…
Pharvaris reported raising $66 million in a second round of financing, allowing the company to advance the clinical development…
People with hereditary angioedema appear to have a higher risk of developing non-alcoholic fatty liver disease, even before receiving…